Data Tables


Sections I - VIII
I. Summary Tables
II. Deceased and Living Donor Characteristics
III. Deceased Donor Organ Recovery and Disposition
IV. Organ Procurement Organization Tables
V. Kidney Tables
VI. Pancreas Transplant Alone (PTA) Tables
VII. Pancreas After Kidney (PAk) Tables
VIII. Kidney-Pancreas Tables
Sections IX - XV
IX. Liver Tables
X. Intestine Tables
XI. Heart Tables
XII. Lung Tables
XIII. Heart-Lung Tables
XIV. Donor and Recipient Tumor Tables
XV. Supplementary Tables
  Technical Notes and Analytic Methods
  All Data Tables (214 K)

View HTML View PDF

Section VI
6.1aWaiting List Patient Characteristics at End of Year Pancreas Transplant Alone (PTA) Waiting List Active Waitlist Patients, 1995 to 2004Table 6.1a (39 k)
Age
Blood Type
Residency
Gender
Previous Transplant Any Organ
Race
Previous Transplant Same Organ
Time on Waiting List
6.1bWaiting List Patient Characteristics at End of Year Pancreas Transplant Alone (PTA) Waiting List Active and Inactive Patient Comparison, 2000 to 2004Table 6.1b (33 k)
Age
Gender
Race
Time on Waiting List
6.2Time to Transplant, 1995 to 2004 New Pancreas Transplant Alone (PTA) Waiting List RegistrationsTable 6.2 (56 k)
Blood Type
Age
Gender
All Patient Types
Previous Transplant Any Organ
Race
Residency
6.3Reported Deaths and Annual Death Rates Per 1,000 Patient-Years at Risk, 1995 to 2004 Pancreas Transplant Alone (PTA) Waiting ListTable 6.3 (40 k)
Age
Blood Type
Gender
Race
6.4Transplant Recipient Characteristics, 1995 to 2004 Pancreas Transplant Alone (PTA) RecipientsTable 6.4 (40 k)
Age
Blood Type
Residency
Gender
Race
Cold Ischemia Time
Hospitalized at Transplant
Previous Transplant Same Organ
Previous Transplant Any Organ
Payment Source
6.5Incidence of Transplant, 1995 to 2004 Pancreas Transplant Alone (PTA) Transplants per 1 Million PopulationTable 6.5 (29 k)
6.6aImmunosuppression Use for Induction, 1995 to 2004 Recipients with Pancreas Transplant Alone (PTA) TransplantsTable 6.6a (30 k)
6.6bImmunosuppression Use for Induction by Discharge Regimen, 2000 to 2004 Recipients with Pancreas Transplant Alone (PTA) TransplantsTable 6.6b (32 k)
6.6cImmunosuppression Use for Induction by Steroid Use at Discharge, 2000 to 2004 Recipients with Pancreas Transplant Alone (PTA) TransplantsTable 6.6c (29 k)
6.6dImmunosuppression Use for Maintenance by Regimen Prior to Discharge, 1995 to 2004 Recipients with Pancreas Transplant Alone (PTA) TransplantsTable 6.6d (30 k)
6.6eImmunosuppression Use for Maintenance Prior to Discharge, 1995 to 2004 Recipients with Pancreas Transplant Alone (PTA) TransplantsTable 6.6e (31 k)
6.6fImmunosuppression Use for Maintenance by Regimen One Year Following Transplantation, 1994 to 2003 Recipients with Pancreas Transplant Alone (PTA) TransplantsTable 6.6f (31 k)
6.6gImmunosuppression Use for Maintenance Between Discharge and One Year Following Transplantation, 1994 to 2003 Recipients with Pancreas Transplant Alone (PTA) TransplantsTable 6.6g (31 k)
6.6hPersistency of Discharge Regimen by Follow-up Period, 1999 to 2003 Recipients with Pancreas Transplant Alone (PTA) TransplantsTable 6.6h (34 k)
6.6iImmunosuppression Use for Antirejection Treatment from Transplant to One Year Following Transplantation, 1994 to 2003 Recipients with Pancreas Transplant Alone (PTA) TransplantsTable 6.6i (30 k)
6.7Patients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1995 to 2003 Rates for Recipients during First Year after Pancreas Transplant Alone (PTA) TransplantationTable 6.7 (65 k)
Blood Type
Residency
Gender
Race
Age of Donor
Age
Cold Ischemia Time
Hospitalized at Transplant
Level of HLA Mismatch
Previous Transplant Any Organ
6.8Adjusted Graft Survival, Pancreas Transplant Alone (PTA) Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 YearsTable 6.8 (31 k)
Age
Gender
Race
6.9Unadjusted Graft Survival, Pancreas Transplant Alone (PTA) Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 YearsTable 6.9 (41 k)
Age
Blood Type
Residency
Gender
Race
Center Volume
Age of Donor
Cold Ischemia Time
Hospitalized at Transplant
Level of HLA Mismatch
6.10Unadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, and 5 Years Pancreas Transplant Alone (PTA) TransplantsTable 6.10 (29 k)
6.11Adjusted Patient Survival, Pancreas Transplant Alone (PTA) Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 YearsTable 6.11 (31 k)
Age
Gender
Race
6.12Unadjusted Patient Survival, Pancreas Transplant Alone (PTA) Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 YearsTable 6.12 (41 k)
Age
Blood Type
Residency
Gender
Race
Center Volume
Age of Donor
Cold Ischemia Time
Hospitalized at Transplant
Level of HLA Mismatch
6.13Unadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, and 5 Years Pancreas Transplant Alone (PTA) TransplantsTable 6.13 (29 k)
6.14Prevalence of People Living with a Functioning Transplant at End of Year Pancreas Transplant Alone (PTA) Recipients, 1995 to 2004Table 6.14 (38 k)
Blood Type
Residency
Gender
Race
Age
Hospitalized at Transplant
Previous Transplant Same Organ
Previous Transplant Any Organ
6.15Transplants by State and Transplant Center, 1995 to 2004 Pancreas Transplant Alone (PTA)Table 6.15 (54 k)